Immix Biopharma Q3 EPS $(0.19), Inline
Benzinga Newsdesk 3 days ago
NewsEarnings
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Immix Biopharma (NASDAQ:IMMX) reported quarterly losses of $(0.19) per share which met the analyst consensus estimate. This is a 20.83 percent increase over losses of $(0.24) per share from the same period last year.
Immix Biopharma (NASDAQ:IMMX) reported quarterly losses of $(0.19) per share which met the analyst consensus estimate. This is a 20.83 percent increase over losses of $(0.24) per share from the same period last year.
